Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

Check the time stamp on this data. Updated AI-Generated Signals for 10x Genomics Inc. (TXG) available here: TXG. Type a few ...

February 07, 2025, 07:36 AM ET, BY Rick W., Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

After reaching all-time nominal highs amid sustained haven demand, gold prices plateaued in 4Q24, ending the quarter with a ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Detailed price information for Torex Gold Resources Inc (TXG-T) from The Globe and Mail including charting and trades.